{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:13:05Z","timestamp":1784308385867,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NHS Wales Valuebased health care evergreen fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11096-024-01790-2","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T12:30:38Z","timestamp":1724761838000},"page":"1247-1255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Implementation and evaluation of pharmacist-led heart failure diagnostic and guideline directed medication therapies clinic"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1881-9220","authenticated-orcid":false,"given":"Angharad","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhian","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teleri","family":"Cudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gethin","family":"Hopley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Smout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"issue":"17","key":"1790_CR1","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2022","unstructured":"Savarese G, Becher P, Lund L, et al. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022;118(17):3272\u201387.","journal-title":"Cardiovasc Res"},{"key":"1790_CR2","unstructured":"British Society Of Heart Failure. 25IN25. Website: https:\/\/www.bsh.org.uk\/25in25.%20%20Accessed%206%20April%202024. Accessed 6 Apr 2024."},{"key":"1790_CR3","unstructured":"Gibson, G., Blumer, V. Mentz, R. et al. Universal Definition and classification of heart failure: a step in the right direction from failure to function. july 2021. American college of cardiology foundation. Website https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2021\/07\/12\/12\/31\/universal-definition-and-classification-of-heart-failure. Accessed 9 May 2024."},{"issue":"36","key":"1790_CR4","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"T McDonagh","year":"2021","unstructured":"McDonagh T, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"issue":"18","key":"1790_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1161\/CIR.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozhurt B, Aguilar D, et al. AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circ J. 2022;145(18):895\u20131032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063.","journal-title":"Circ J"},{"key":"1790_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3399\/BJGPO.2021.0006","volume":"5","author":"CJ Taylor","year":"2021","unstructured":"Taylor CJ, Hartshorne-Evans N, Satchithanada D, et al. Faster diagnosis: Time to Beat heart failure. BJCP Open. 2021;5:1\u20134. https:\/\/doi.org\/10.3399\/BJGPO.2021.0006.","journal-title":"BJCP Open"},{"key":"1790_CR7","unstructured":"All Wales Therapeutic and Toxicology Centre. Website: https:\/\/awttc.nhs.wales\/medicines-optimisation-and-safety\/medicines-optimisation-guidance-resources-and-data\/acknowledged-resources\/#Heart%20Failure%20in%20Wales. Accessed 6 Apr 2024."},{"issue":"6","key":"1790_CR8","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/eurheartj\/ehaa1012","volume":"42","author":"J Bauersachs","year":"2021","unstructured":"Bauersachs J. Heart failure drug treatment: the fantastic four. Eur Heart J. 2021;42(6):681\u20133.","journal-title":"Eur Heart J"},{"issue":"1","key":"1790_CR9","doi-asserted-by":"publisher","first-page":"e001585","DOI":"10.1136\/openhrt-2021-001585","volume":"8","author":"S Straw","year":"2021","unstructured":"Straw S, McGinlay M, Witte KK. Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction. Open Heart. 2021;8(1):1\u20134.","journal-title":"Open Heart."},{"key":"1790_CR10","unstructured":"NICE Guidelines. Chronic heart failure in adults: diagnosis and management [NG106]. 2018. https:\/\/www.nice.org.uk\/guidance\/ng106. Accessed 9 May 2024."},{"issue":"7","key":"1790_CR11","first-page":"862","volume":"4","author":"FS Viven","year":"2021","unstructured":"Viven FS, Cao BS, Cowley E, et al. Pharmacist-led optimization of heart failure medications. A Syst Rev. 2021;4(7):862\u201370.","journal-title":"A Syst Rev"},{"key":"1790_CR12","first-page":"1","volume":"5","author":"S Ladhar","year":"2024","unstructured":"Ladhar S, Hawkins N, Virani SA, et al. Evaluation of PHARM-HF, a pharmacist-led heart failure medication titration clinic. A Pre-Post Study. 2024;5:1\u201310.","journal-title":"A Pre-Post Study"},{"issue":"7","key":"1790_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IPRP.S137882","volume":"9","author":"J Cheng","year":"2018","unstructured":"Cheng J. Current perspectives on the role of the pharmacist in heart failure management. Int Pharm Res Pract. 2018;9(7):1\u201311. https:\/\/doi.org\/10.2147\/IPRP.S137882.","journal-title":"Int Pharm Res Pract"},{"issue":"6","key":"1790_CR14","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1007\/s12265-022-10262-9","volume":"15","author":"T Patil","year":"2022","unstructured":"Patil T, Ali S, Kaur A, et al. Impact of pharmacist-led heart failure clinic on optimization of guideline-directed medical therapy (PHARM-HF). J Cardiovasc Trans Res. 2022;15(6):1424\u201335.","journal-title":"J Cardiovasc Trans Res."},{"issue":"13","key":"1790_CR15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/eurjhf\/hfr083","volume":"8","author":"R Lowrie","year":"2011","unstructured":"Lowrie R, Frances MS, Greenlaw N, et al. The Heart failure and optimal outcomes from pharmacy study (HOOPS): rationale, design, and baseline characteristics. Eur J Heart Fail. 2011;8(13):917\u201324.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"1790_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/ijpp.12465","volume":"27","author":"P Forsyth","year":"2019","unstructured":"Forsyth P, Warren A, Thomson C, et al. A competency framework for clinical pharmacists and heart failure. Int J Pharm Pract. 2019;27(5):424\u201335.","journal-title":"Int J Pharm Pract"},{"issue":"7","key":"1790_CR17","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1592\/phco.19.10.860.31565","volume":"19","author":"S Varma","year":"1999","unstructured":"Varma S, McElnay JC, Hughes CM, et al. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharm J Human Pharmacol Drug Therapy. 1999;19(7):860\u20139. https:\/\/doi.org\/10.1592\/phco.19.10.860.31565.","journal-title":"Pharm J Human Pharmacol Drug Therapy"},{"issue":"3","key":"1790_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/eurheartj\/ehr433","volume":"33","author":"R Lowrie","year":"2012","unstructured":"Lowrie R, Mair FS, Greenlaw N, et al. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur Heart J. 2012;33(3):314\u201324.","journal-title":"Eur Heart J"},{"issue":"5","key":"1790_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1054\/S1071-9164(03)00130-1","volume":"9","author":"ML Bouvy","year":"2003","unstructured":"Bouvy ML, Heerdint E, Urquhart z J, et al. Urquhart et al effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled trial. J Card Fail. 2003;9(5):404\u201311.","journal-title":"J Card Fail"},{"issue":"6","key":"1790_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S1130-6343(06)74004-1","volume":"30","author":"C L\u00f3pez Cabezas","year":"2006","unstructured":"L\u00f3pez Cabezas C, Falces Salvador C, Cub\u00ed Quadrada D, et al. Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failure. Farm Hosp. 2006;30(6):328\u201342. https:\/\/doi.org\/10.1016\/S1130-6343(06)74004-1.","journal-title":"Farm Hosp"},{"key":"1790_CR21","doi-asserted-by":"crossref","unstructured":"Kowal, C. Eliahou, L. Haver, S. et al. Therapy education programme in heart failure-3 year evaluation. Euro J Hosp Pharm 2016; 23(1): A77. https:\/\/ejhp.bmj.com\/content\/23\/Suppl_1\/A77.1. Accessed 10 May2024.","DOI":"10.1136\/ejhpharm-2016-000875.174"},{"key":"1790_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ijcard.2015.10.206","volume":"203","author":"T Roblek","year":"2016","unstructured":"Roblek T, Eliahou L, Haver S, et al. Clinical-pharmacist intervention reduces clinically relevant drug-drug interactions in patients with heart failure: a randomized, double blind, controlled trial. Int J Cardiol. 2016;203:647\u201352. https:\/\/doi.org\/10.1016\/j.ijcard.2015.10.206.","journal-title":"Int J Cardiol"},{"key":"1790_CR23","doi-asserted-by":"publisher","first-page":"A165","DOI":"10.1136\/ejhpharm-2013-000276.458","volume":"20","author":"O Jullion","year":"2013","unstructured":"Jullion O, Sterckx P, Huez S, et al. CPC-001 A clinical Pharmacist for outpatient consultations in a heart failure clinic. Eur J Hosp Pharm. 2013;20:A165\u2013A165.https:\/\/www.researchgate.net\/publication\/273201855_CPC-001_A_Clinical_Pharmacist_For_Outpatient_Consultations_in_a_Heart_Failure_Clinic.","journal-title":"Eur J Hosp Pharm"},{"issue":"5","key":"1790_CR24","doi-asserted-by":"publisher","first-page":"982.e1","DOI":"10.1016\/j.ahj.2005.08.016","volume":"150","author":"FH Gwadry-Sridhar","year":"2005","unstructured":"Gwadry-Sridhar FH, Malcolm J, Arnold O, et al. Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure. Am Heart J. 2005;150(5):982.e1-982.e9. https:\/\/doi.org\/10.1016\/j.ahj.2005.08.016.","journal-title":"Am Heart J"},{"issue":"16","key":"1790_CR25","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1001\/archinte.159.16.1939","volume":"159","author":"WA Gattis","year":"1999","unstructured":"Gattis WA, Hasselblad V, Whellan DJ, et al. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the pharmacist in heart failure assessment recommendation and monitoring (PHARM). Arch Intern Med. 1999;159(16):1939\u201345.","journal-title":"Arch Intern Med"},{"issue":"13","key":"1790_CR26","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/ajhp\/56.13.1339","volume":"56","author":"EC Rainville","year":"1999","unstructured":"Rainville EC. Impact of pharmacist interventions on hospital readmissions for heart failure. Am J Health Syst Pharm. 1999;56(13):1339\u201342.","journal-title":"Am J Health Syst Pharm"},{"issue":"10","key":"1790_CR27","doi-asserted-by":"publisher","first-page":"714","DOI":"10.7326\/0003-4819-146-10-200705150-00005","volume":"146","author":"MD Murray","year":"2007","unstructured":"Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007;146(10):714\u201325.","journal-title":"Ann Intern Med"},{"issue":"10","key":"1790_CR28","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1001\/archinte.158.10.1067","volume":"158","author":"S Stewart","year":"1998","unstructured":"Stewart S, Pearson S, Horowitz JD, et al. Effects of a homebased intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med. 1998;158(10):1067\u201372.","journal-title":"Arch Intern Med"},{"key":"1790_CR29","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/CIRCHEARTFAILURE.109.861013","volume":"2","author":"EE Roughead","year":"2009","unstructured":"Roughead EE, Barratt JD, Ramsay E, et al. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circ Heart Fail. 2009;2:424\u20138. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.861013.","journal-title":"Circ Heart Fail"},{"issue":"2","key":"1790_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2125.2005.02387.x","volume":"60","author":"A Sadik","year":"2005","unstructured":"Sadik A, Yousif M, McElnay JC. Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol. 2005;60(2):183\u201393.","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"1790_CR31","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1016\/j.cardfail.2011.06.366","volume":"17","author":"KX Ong","year":"2011","unstructured":"Ong KX, Lee HK, Yeo D. An evaluation of pharmacist-led heart failure clinic in Tan Tock Seng Hospital. J Cardiac Fail. 2011;17(8):352. https:\/\/doi.org\/10.1016\/j.cardfail.2011.06.366.","journal-title":"J Cardiac Fail"},{"key":"1790_CR32","unstructured":"Welsh Government. Hywel Dda Health Board Profile. Website https:\/\/www.gov.wales\/sites\/default\/files\/statistics-and-research\/2018-12\/160622-workforce-welsh-language-support-primary-care-hywel-dda-en.pdf. Accessed 26 Apr 2024."},{"key":"1790_CR33","unstructured":"Royal Pharmaceutical Society. Website https:\/\/www.rpharms.com\/resources\/frameworks\/advanced-pharmacy-framework-apf. Accessed 10 May 2024."},{"issue":"5","key":"1790_CR34","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s11096-021-01276-5","volume":"43","author":"P Forsyth","year":"2021","unstructured":"Forsyth P, Rushworth GF. Advanced pharmacist practice: where is the United Kingdom in pursuit of this \u201cBrave New World\u201d? Int J Clin Pharm. 2021;43(5):1426\u201330.","journal-title":"Int J Clin Pharm"},{"issue":"24","key":"1790_CR35","first-page":"00197","volume":"S1551\u20137411","author":"GF Rushworth","year":"2024","unstructured":"Rushworth GF, Forsyth P, Radley A, et al. A Pharmacist Clinician Model as part of a collaborative clinical workforce: a philosophical critique. Res Social Adm Pharm. 2024;S1551\u20137411(24):00197\u20139.","journal-title":"Res Social Adm Pharm"},{"key":"1790_CR36","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s11096-021-01275-6","volume":"43","author":"D Terry","year":"2021","unstructured":"Terry D, Ganasan S, Aiello M, et al. Pharmacists in advanced clinical practice roles in emergency departments (PARED). Int J Clin Pharm. 2021;43:1523\u201332. https:\/\/doi.org\/10.1007\/s11096-021-01275-6.","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"1790_CR37","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s11096-022-01484-7","volume":"44","author":"GF Rushworth","year":"2022","unstructured":"Rushworth GF, Jebara T, Tonna AP, et al. General practice pharmacists\u2019 implementation of advanced clinical assessment skills: a qualitative study of behavioural determinants. Int J Clin Pharm. 2022;44(6):1417\u201324.","journal-title":"Int J Clin Pharm"},{"issue":"23","key":"1790_CR38","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1016\/j.jacc.2023.04.010","volume":"81","author":"L Stevenson","year":"2023","unstructured":"Stevenson L, Ross H, Rathman L, et al. Remote Monitoring for Heart Failure Management at Home: JACC Scientific Statement. J Am Coll Cardiol. 2023;81(23):2272\u201391.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1790_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ejhf.2033","volume":"23","author":"T Bekfani","year":"2021","unstructured":"Bekfani T, Fudim M, Cleland JGF, et al. A current and future outlook on upcoming technologies in remote monitoring of patients with heart failure. Eur J Heart Fail. 2021;23(1):175\u201385. https:\/\/doi.org\/10.1002\/ejhf.2033.","journal-title":"Eur J Heart Fail"},{"key":"1790_CR40","unstructured":"NHS Wales. Cardiovascular Atlas of Variation, 2019. executive.nhs.wales\/functions\/networks-and-planning\/cardiovascular\/cvn-docs\/cardiovascularatlasofvariation-march2019-pdf\/. Accessed 26 Apr 2024."},{"key":"1790_CR41","unstructured":"Welsh Government. A Healthier Wales:our plan for Health and Social Care. 2018. https:\/\/www.gov.wales\/sites\/default\/files\/publications\/2021-09\/a-healthier-wales-our-plan-for-health-and-social-care.pdf. Accessed 10 Apr 2024."},{"key":"1790_CR42","unstructured":"Welsh Government. Heart Conditions Delivery Plan, 2017 https:\/\/www.gov.wales\/sites\/default\/files\/publications\/2019-01\/heart-conditions-delivery-plan-january-2017.pdf. Accessed 10 Apr 2024."},{"issue":"3","key":"1790_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2019-000676","volume":"8","author":"P Forsyth","year":"2019","unstructured":"Forsyth P, Moir L, Speirits I, et al. Improving medication optimisation in left ventricular systolic dysfunction after acute myocardial infarction. BMJ Open Qual. 2019;8(3):1\u201310.","journal-title":"BMJ Open Qual"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-024-01790-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T02:09:27Z","timestamp":1732068567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-024-01790-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1790"],"URL":"https:\/\/doi.org\/10.1007\/s11096-024-01790-2","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}